Human CEA (recombinant)

ID: RP_SZ_196 Category:

InVivo offers a recombinant form of Human Carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5 or CEA).

The recombinant protein is produced under serum‐free conditions in optimized HEK293-cell system and purified through using ion exchange chromatography and Size Exclusion Chromatography.

In stock

Delivery time: 2-5 days

From: 270,00 € Excl. VAT and delivery costs

Please contact us for larger quantities.

InVivo offers a recombinant form of Human Carcinoembryonic antigen-related cell
adhesion molecule 5 (CEACAM5 or CEA), which is produced under serum‐free conditions in
HEK 293 cells.

The expression construct contains residues 1 to 677 of human CEA and with a 25 amino acid
C-terminal truncation (Δ678–702) compared to full-length CEA, which contains 702 amino acids.

The amino acid sequence is identical to residues 1 to 677 of GenBank entry AAA62835.1. With
respect to reviewed UniProtKB entry P06731, this construct contains five sequence deviations:
N359I, N360I, Q361R, F641L, T646Q.

The recombinant protein is produced under serum‐free conditions in optimized HEK293-cell
system and purified through using ion exchange chromatography and Size Exclusion
Chromatography.

 

Product-ID: RP_SZ_196
Expression System: Mammalian; HEK
Protein Accession # : P06731
Amino Acids: Met1–Ser677
Mutations: N359I, N360I, Q361R, F641L, T646Q
Mature Protein N-Term: Lys35 (predicted)
Tag: none
Expected Molecular Weight: 70.7 kDa (glycosylated form runs at 85-200 kDa on SDS-PAGE)
Formulation: Liquid, PBS, pH 7.4
Concentration: ≥ 0.5 mg/mL (photometric)
Activity: CEA Kryptor assay
Purity: ≥ 90 % (Analytical SEC)

 

The product is for research use or for further manufacturing only and not for use in diagnostic or therapeutic procedures.

Additional information

Document

Product Information Sheet – RP_SZ_196

Notice

The product is for research use or for further manufacturing only and not for use in diagnostic or therapeutic procedures.

Reviews

There are no reviews yet.

Be the first to review “Human CEA (recombinant)”